Arab Finance: Kahira Pharmaceuticals and Chemical Industries Company (CPCI) unveiled cash dividends distribution of EGP 12.83 per share for the fiscal year (FY) 2023/2024, according to a bourse statement on 11th December.
The company will disburse the dividends on December 26th, 2024, through the exchange outlets of Misr Clearing Company for Central Depository and Registry.
In FY2023/24, the EGX-listed firm posted 153.5% higher net profit after tax at EGP 246.132 million, compared to EGP 97.092 million in the previous FY.
Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.